Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 15/20 | 0.42 |
| ▸ | CTSL | P07711 | 7/20 | 0.42 |
| ▸ | CTSS | P25774 | 5/20 | 0.42 |
| ▸ | CTSB | P07858 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7380606 | 0.95 | CTSK (0.40) | CTSKCTSLCTSSCTSBCYP3A4 | |
| SCHEMBL7377048 | 0.93 | CTSK (0.41) | CTSKCTSLCTSSCTSBCYP3A4 | |
| SCHEMBL7384005 | 0.90 | CTSK (0.41) | CTSKCTSLCTSSCTSBCYP3A4 | |
| SCHEMBL7762282 | 0.89 | CYP3A4 (0.43) | CTSKCTSLCTSSCTSBCYP3A4 | |
| SCHEMBL7425528 | 0.89 | CTSK (0.42) | CTSKCTSLCTSSCTSBCYP3A4 | |
| SCHEMBL7384528 | 0.87 | CTSK (0.43) | CTSKCTSLCTSSCTSBCYP3A4 | |
| SCHEMBL7381006 | 0.86 | CTSK (0.39) | CTSKCTSLCTSSCTSBCYP3A4 | |
| SCHEMBL7381556 | 0.84 | NMBR (0.41) | CTSKCTSB | |
| SCHEMBL7381284 | 0.84 | CTSK (0.41) | CTSKCTSLCTSSCTSBCYP3A4 | |
| SCHEMBL7384376 | 0.83 | CYP3A4 (0.41) | CTSKCTSLCTSSCTSBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1098662-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2001-05-16 | — | — | EP | disclosed |
| EP-1047450-A1 | ACE INHIBITOR-MMP INHIBITOR COMBINATIONS | WARNER-LAMBERT COMPANY (US) | 2000-11-02 | — | — | EP | disclosed |
| WO-2000004892-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2000-02-03 | — | — | WO | disclosed |
| WO-1999032150-A1 | ACE INHIBITOR-MMP INHIBITOR COMBINATIONS | WARNER-LAMBERT COMPANY (US) | 1999-07-01 | — | — | WO | disclosed |